South Carolina has an expanding biotech infrastructure comprised of life science-related research and development, manufacturing and service companies. Internationally recognized names such as Bausch & Lomb, Capsugel, GlaxoSmithKline, Holopack and Roche have operations in South Carolina. Now, armed with legislation designed to increase the availability of incentives, research and capital for the life sciences, the possibilities for biotech are better than ever.
